Wholesaler AmerisourceBergen and competitor McKesson report earnings; Merck expands work with Synthace;

> London-based Synthace said it has expanded an agreement to work with Merck & Co. ($MRK) on processes to use Synthace's bioprocesses and computer language Antha on a biomanufacturing platform for a number of undisclosed Merck molecules. Release

> Drug wholesaler AmerisourceBergen ($ABC) reported adjusted earnings of $1.17 per share for its fourth quarter, missing Wall Street projections of $1.18 per share. Report

> Drug wholesaling and services company McKesson ($MCK) reported adjusted earnings of $3.31 per share, well above analyst expectations of $2.97 per share. Report